3 Marijuana Stocks For Your Cannabis Investing Portfolio On 420

The people looking for the top marijuana stocks to watch, there are several sectors to consider. Each company inside the cannabis industry offers different values even in the same space. For example, if you are looking for a safer play then ancillary marijuana stocks could be for you. The reason for the less risk is most ancillary companies do not solely rely on the cannabis sector to run their business. So in the event, a non-cannabis part of the company does well it can reflect in trading.

If you are willing to risk more for a bigger reward then looking into pure play or MSO marijuana stocks could be the way to go. It has been a while since the cannabis sector has seen a decline in volatile trading. With the increase in volatility has come both a lack of momentum and chances to find top marijuana stocks to buy. Often when a sector is experiencing volatility it leads to unpredictable trading patterns resulting in more pullback than recovery.

Even with the cannabis sector in this position, it can be seen as a time to prepare for future trading. The more you diversify your portfolio the greater the chances of seeing better profitability. Like always remember to do your homework prior to executing any trades. The companies below are several marijuana stocks to watch in the stock market.

Top Marijuana Stocks For Cannabis Investing

  1. Cronos Group Inc. (NASDAQ:CRON)
  2. Organigram Holdings Inc. (NASDAQ:OGI)
  3. HEXO Corp. (NASDAQ:HEXO)

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company bolsters its Spinach® Infused Pre-roll Portfolio with CBG, CBC, and CBN. Pre-rolls are one of the fastest-growing categories in the Canadian cannabis market. cron stock

The category increased 38% year-over-year during the three months that ended March 31, 2023. Infused pre-rolls accounted for approximately 24% of the dollar share in pre-rolls during the same period. Utilizing our success in the edibles category as a blueprint for other product formats. Cronos continues to elevate and differentiate the consumer experience by bringing a portfolio of infused pre-rolls to market.

Organigram Holdings Inc.

Organigram Holdings Inc. through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. Organigram In recent news, the company reported its second-quarter fiscal 2023 results.

FINANCIAL HIGHLIGHTS

  • Net revenue of $39.5 million, up 24% from $31.8 million in the same prior-year period.
  • Adjusted Gross Margin1 of $13.4 million or 34%, compared to $8.3 million or 26% in the same prior year period, reflecting improvements from increased efficiencies, higher sales volume, and increased international sales.
  • Adjusted EBITDA1 of $5.6 million, the fifth consecutive quarter of positive Adjusted EBITDA, compared to Adjusted EBITDA of $1.6 million in the same prior year period.

[Read More] 2 Canadian Marijuana Stocks To Watch For This Weeks Trading

Words From The Company

“We are pleased with our results in a quarter with typical seasonality. Our market position remains competitive, supported by our leading brand portfolio, strong international sales, and customer-focused innovation,” said Beena Goldenberg, Chief Executive Officer.

[Read More] 3 Marijuana Stocks To Watch 3rd Week Of April

HEXO Corp.

HEXO Corp. together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. Back on April 10th, the company reported it is being acquired by Tilray Brands. So Tilray will acquire all of the issued and outstanding common shares of Hexo Corp. This venture is subject to approval by the holders of HEXO Shares and the satisfaction or waiver of other closing conditions. HEXO stock

Under the terms of the Arrangement Agreement, HEXO Shareholders will receive 0.4352 of a share of Tilray common stock. This will be in exchange for each HEXO Share held which implies a purchase price of US$1.25 per HEXO Share based on the volume weighted average price of Tilray Shares on the Nasdaq Stock Market. Which is for the 60-day period that ended on April 5, 2023.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Workers Part Timing in The #Marijuana Industry Brings Challenges for CEOs

Part-Time Cannabusiness Workers Create Challenges for CEOs Legalized marijuana is gaining employment…